Literature DB >> 19096814

[Cutaneous metastases from malignancies which do not originate from the skin. An epidemiological study].

P Itin1, S Tomaschett.   

Abstract

The objective of our study was to get epidemiological data in the region of Aarau, Switzerland, about the frequency of cutaneous metastases from visceral malignancies. With a computer search we analyzed all patients with skin metastases from visceral malignancies who had attended our clinic between January 1, 1998, and December 31, 2003. Out of 19 491 patients, 37 had cutaneous metastases from visceral tumours (0,19%): 25 women (67.5%) and 12 men (32.5%) were affected. 19 had breast cancer (51%), 8 sarcomas (21%), 2 leukemia (5%), 2 colorectal cancer, and one each ovary carcinoma, bronchial cancer, prostate cancer, malignant histiocytoma and Non-Hodgkin lymphoma (3%). In 24 cases the primary malignancy was known (65%). In 35% cutaneous metastases were diagnosed at the same time as the primary tumour. Primary malignancies were diagnosed in 54% within the age range of 50-70 years, and 65% of cutaneous metastases were diagnosed within the age range of 50-80 years. In 51% skin metastases were the first site of dissemination. In 49% other known metastases were present (5% locoregional, 38% lymph nodes, 3% brain, 3% lung, 3% liver). Our study documents that cutaneous metastases from visceral malignancies are rare. However, early diagnosis has an impact concerning further treatment and prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19096814     DOI: 10.1007/s00108-008-2208-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

1.  [Survival after cutaneous metastasis: a study of 200 cases].

Authors:  P Schoenlaub; A Sarraux; E Grosshans; E Heid; B Cribier
Journal:  Ann Dermatol Venereol       Date:  2001-12       Impact factor: 0.777

2.  Spread of tumors to the skin.

Authors:  M H Brownstein; E B Helwig
Journal:  Arch Dermatol       Date:  1973-01

3.  Patterns of cutaneous metastasis.

Authors:  M H Brownstein; E B Helwig
Journal:  Arch Dermatol       Date:  1972-06

4.  Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients.

Authors:  D P Lookingbill; N Spangler; F M Sexton
Journal:  J Am Acad Dermatol       Date:  1990-01       Impact factor: 11.527

5.  Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients.

Authors:  D P Lookingbill; N Spangler; K F Helm
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

6.  Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal.

Authors:  Sadia Saeed; Connie A Keehn; Michael B Morgan
Journal:  J Cutan Pathol       Date:  2004-07       Impact factor: 1.587

7.  Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.

Authors:  Dinesh Sariya; Karen Ruth; Rose Adams-McDonnell; Carrie Cusack; XiaoWei Xu; Rosalie Elenitsas; John Seykora; Terri Pasha; Paul Zhang; Marisa Baldassano; Stuart R Lessin; Hong Wu
Journal:  Arch Dermatol       Date:  2007-05

Review 8.  [Cutaneous metastases of internal cancers].

Authors:  J Kanitakis
Journal:  Presse Med       Date:  1993-04-10       Impact factor: 1.228

9.  Spectrum of cutaneous metastases in 1287 cases of internal malignancies: a study from Turkey.

Authors:  Ulker Gül; Arzu Kiliç; Müzeyyen Gönül; Seray Külcü Cakmak; Ceren Erinçkan
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

  9 in total
  2 in total

1.  [Bilateral periorbital metastases of transtional cell carcinoma of the bladder].

Authors:  I Fierlbeck; P Helmbold
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

2.  Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases.

Authors:  Silvia González-Martínez; David Pizarro; Belén Pérez-Mies; Tamara Caniego-Casas; José Luis Rodríguez-Peralto; Giuseppe Curigliano; Alfonso Cortés; María Gión; Javier Cortés; José Palacios
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.